36 related articles for article (PubMed ID: 35892269)
1. Constructing a personalized prognostic risk model for colorectal cancer using machine learning and multi-omics approach based on epithelial-mesenchymal transition-related genes.
Zhang S; Fan W; He D
J Gene Med; 2024 Jan; 26(1):e3660. PubMed ID: 38282145
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Factors Involved in the Epithelial-Mesenchymal Transition Process in Colorectal Cancer Have a Preponderant Role in Oxidative Stress: A Systematic Review and Meta-Analysis.
Parisi E; Sorolla A; Montal R; González-Resina R; Novell A; Salud A; Sorolla MA
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33187205
[TBL] [Abstract][Full Text] [Related]
3. Novel biomarkers for patient stratification in colorectal cancer: A review of definitions, emerging concepts, and data.
Chand M; Keller DS; Mirnezami R; Bullock M; Bhangu A; Moran B; Tekkis PP; Brown G; Mirnezami A; Berho M
World J Gastrointest Oncol; 2018 Jul; 10(7):145-158. PubMed ID: 30079141
[TBL] [Abstract][Full Text] [Related]
4. Towards precision oncology discovery: four less known genes and their unknown interactions as highest-performed biomarkers for colorectal cancer.
Liu Y; Xu Y; Li X; Chen M; Wang X; Zhang N; Zhang H; Zhang Z
NPJ Precis Oncol; 2024 Jan; 8(1):13. PubMed ID: 38243058
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein family A member 8 serving as a co-activator of transcriptional factor ETV4 up-regulates PHLDA2 to promote the growth of liver cancer.
Wang S; Wang YF; Yang G; Zhang HH; Yuan HF; Hou CY; Zhao LN; Suo YH; Sun J; Sun LL; Lv P; Sun Y; Zhang NN; Zhang XD; Lu W
Acta Pharmacol Sin; 2023 Dec; 44(12):2525-2536. PubMed ID: 37474643
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic role and drug sensitivity of ETV4 in human tumors: a pan-cancer analysis.
Zhang R; Peng Y; Gao Z; Qian J; Yang K; Wang X; Lu W; Zhu Y; Qiu D; Jin T; Wang G; He J; Liu N
Front Oncol; 2023; 13():1121258. PubMed ID: 37205199
[TBL] [Abstract][Full Text] [Related]
7. Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology.
Chaudhuri A; Kumar DN; Dehari D; Patil R; Singh S; Kumar D; Agrawal AK
Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174125
[TBL] [Abstract][Full Text] [Related]
8. The role of ETV4 in HCC: How transcription factors can inform immunotherapy combination treatments.
Craig AJ; Silveira MAD
J Hepatol; 2023 Jul; 79(1):19-21. PubMed ID: 37088313
[No Abstract] [Full Text] [Related]
9. Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells.
Cherradi S; Garambois V; Marines J; Andrade AF; Fauvre A; Morand O; Fargal M; Mancouri F; Ayrolles-Torro A; Vezzo-Vié N; Jarlier M; Loussaint G; Huvelle S; Joubert N; Mazard T; Gongora C; Pourquier P; Boissière-Michot F; Rio MD
Cell Biosci; 2023 Apr; 13(1):72. PubMed ID: 37041570
[TBL] [Abstract][Full Text] [Related]
10. ETV4 Mediated Tumor-Associated Neutrophil Infiltration Facilitates Lymphangiogenesis and Lymphatic Metastasis of Bladder Cancer.
Zhang Q; Liu S; Wang H; Xiao K; Lu J; Chen S; Huang M; Xie R; Lin T; Chen X
Adv Sci (Weinh); 2023 Apr; 10(11):e2205613. PubMed ID: 36670069
[TBL] [Abstract][Full Text] [Related]
11. NKX6.1 Represses Tumorigenesis, Metastasis, and Chemoresistance in Colorectal Cancer.
Chung HH; Lee CT; Hu JM; Chou YC; Lin YW; Shih YL
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707737
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylation of GDNF family receptor alpha 1 promotes epithelial-mesenchymal transition and predicts metastasis of colorectal cancer.
Dong Z; Dai L; Zhang Y; Fang C; Shi G; Chen Y; Li J; Wang Q; Fu J; Yu Y; Wang W; Cheng L; Liu Y; Lin Y; Wang Y; Wang Q; Wang H; Zhang H; Zhang Y; Su X; Zhang S; Wang F; Qiu M; Zhou Z; Deng H
PLoS Genet; 2020 Nov; 16(11):e1009159. PubMed ID: 33175846
[TBL] [Abstract][Full Text] [Related]
13. OVOL2 attenuates the expression of MAP3K8 to suppress epithelial mesenchymal transition in colorectal cancer.
Xia L; Gao J; Ma K; Lin H; Chen Y; Luo Q; Lian J
Pathol Res Pract; 2021 Aug; 224():153493. PubMed ID: 34098198
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Targeting of Epithelial-to-Mesenchymal Transition in Colorectal Cancer.
Zafari N; Velayati M; Nassiri M; Khazaei M; Hassanian SM; Ferns GA; Avan A
Curr Pharm Des; 2022; 28(28):2298-2311. PubMed ID: 35909286
[TBL] [Abstract][Full Text] [Related]
15. Reliable epithelial-mesenchymal transition biomarkers for colorectal cancer detection.
Goettsch KA; Zhang L; Singh AB; Dhawan P; Bastola DK
Biomark Med; 2022 Aug; 16(12):889-901. PubMed ID: 35892269
[No Abstract] [Full Text] [Related]
16. Insights into the molecular mechanisms and signalling pathways of epithelial to mesenchymal transition (EMT) in colorectal cancer: A systematic review and bioinformatic analysis of gene expression.
Azizan S; Cheng KJ; Mejia Mohamed EH; Ibrahim K; Faruqu FN; Vellasamy KM; Khong TL; Syafruddin SE; Ibrahim ZA
Gene; 2024 Feb; 896():148057. PubMed ID: 38043836
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
